NCT06646107Recruiting
Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There a Difference
Source: ClinicalTrials.gov · Last updated 19 Nov 2025
Brief summary (registry, in English)
In this observaltional study, 240 patients aged \>12 years old with T1DM who are on multiple daily injections or insulin pump and are scheduled to start using MiniMed 780G system will be included.We aim to compare patients' adherence to Mediterranean diet (MD) before and 12 weeks after initiation of MiniMed 780G and its association with CGM and insulin metrics, as well as anthropometric measurements, BMI, body composition, lipid levels, blood pressure and gut microbioma. Moreover, at baseline, at six and 12 months, markers of endothelial and cardiovascular function will be also assessed and associated with the use of Minimed 780G and the adherence to MD.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 240 (estimated)
- First submitted
- 13 Oct 2024
- Start date
- 1 Mar 2025
- Primary completion date
- 31 Aug 2025
- Lead sponsor
- Attikon Hospital
- Diseases
- Type 1 diabetes
- NCT number
- NCT06646107
What you commit to
- Study type: Observational
- Planned participants: 240
- From 1 Mar 2025 to the primary completion date, 31 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1\. Diabetic Ketoacidosis in the 6 months prior to screening visits
Other
- \-
Who the study is looking for
- Clinical diagnosis of type 1 diabetes \>1 year prior to consent date. Diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide level and antibody determinations are not required.
- HbA1c \< 12.5%
- Age \>7years at the initiation of the system
- Multiple Daily Injections (Basal Bolus therapy) with Total daily insulin use of great than 8.0 units per day over a 1-week period
- Clinically able to start the AHCL system
- History of 3 clinic visits in the last year
Age in the registry: 12 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Attikon University General Hospital Coordinator of this site? Confirm its status | Chaïdári | Greece | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.